Current Therapeutic Options for Heart Failure in Elderly Patients.

about

Current Therapeutic Options for Heart Failure in Elderly Patients.

Item

http://www.wikidata.org/entity/Q47121564

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Current Therapeutic Options for Heart Failure in Elderly Patients.

@en

Current Therapeutic Options for Heart Failure in Elderly Patients.

@nl

type

Item

label

Current Therapeutic Options for Heart Failure in Elderly Patients.

@en

Current Therapeutic Options for Heart Failure in Elderly Patients.

@nl

prefLabel

Current Therapeutic Options for Heart Failure in Elderly Patients.

@en

Current Therapeutic Options for Heart Failure in Elderly Patients.

@nl

P1476

Current Therapeutic Options for Heart Failure in Elderly Patients.

@en

P2093

A Capucci

http://www.w3.org/2001/XMLSchema#string

M Brambatti

http://www.w3.org/2001/XMLSchema#string

M V Matassini

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Use of implantable cardioverter-defibrillators for primary prevention in older patients: a systematic literature review and meta-analysis

Heart failure outcomes with empagliflozin in patients with type 2 diabetes at high cardiovascular risk: results of the EMPA-REG OUTCOME® trial.

Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction

Angiotensin-neprilysin inhibition versus enalapril in heart failure

Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

Palliative Care and Cardiovascular Disease and Stroke: A Policy Statement From the American Heart Association/American Stroke Association.

Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II.

Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group.

P304

1483873

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1155/2017/1483873

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

2017

http://www.w3.org/2001/XMLSchema#string

P50

Federico Guerra

P5008

ScienceSource

P577

2017-11-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29270425

http://www.w3.org/2001/XMLSchema#string

P921

heart failure

P932

5705868

http://www.w3.org/2001/XMLSchema#string